Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FAWLN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,986
Award facts
- Contract value 100% obligated
- $12,985.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,985.78 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Dupixent 300 mg/2 mL pen injections. The contract, issued on September 15, 2025, with an ultimate completion date of September 16, 2025, contains no set-aside designation. Performance will take place in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, is well-positioned to fulfill this requirement as a key supplier within the federal pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion agreement valid through November 2026. The IDC enables the agency to issue firm fixed-price delivery orders for pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. The current order for Dupixent, a biologic medication indicated for atopic dermatitis and other inflammatory conditions, represents one of numerous pharmaceutical deliveries the company has executed for military health facilities as part of its robust federal contract portfolio.
Quick answers
Who was awarded contract SPE2DB25FAWLN?
SPE2DB25FAWLN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FAWLN worth?
The government has obligated $12,986 on SPE2DB25FAWLN.
Is contract SPE2DB25FAWLN an order under another contract?
Yes. SPE2DB25FAWLN is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAWLN competed?
The extent of competition for SPE2DB25FAWLN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award